The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice

被引:24
作者
Rapozzi, Valentina [1 ]
Zorzet, Sonia [2 ]
Zacchigna, Marina [3 ]
Drioli, Sara [3 ]
Xodo, Luigi E. [1 ]
机构
[1] Sch Med, Dept Med & Biol Sci, I-33100 Udine, Italy
[2] Univ Trieste, Dept Life Sci, I-34100 Trieste, Italy
[3] Univ Trieste, Dept Chem & Pharmaceut Sci, I-34100 Trieste, Italy
关键词
Pheophorbide a; mPEG conjugation; Photodynamic therapy; Melanoma; Mice; IN-VIVO EFFICACY; PHOTODYNAMIC THERAPY; TARGETED DELIVERY; TUMOR-CELLS; PHOTOSENSITIZER; CANCER; CHLOROPHYLL; NANOPARTICLES; KINASE; VITRO;
D O I
10.1007/s10637-012-9844-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pheophorbide a (Pba) is a chlorophyll catabolite that has been proposed as photosensitizer in photodynamic therapy. In a previous study we conjugated Pba to monomethoxy-polyethylene glycol (mPEG-Pba), to increase its solubility and pharmacokinetics. Here, we compare the photodynamic therapy efficacy of free Pba and mPEG-Pba to cure a subcutaneous amelanotic melanoma transplanted in C57/BL6 mice. The photosensitizers, i.p. injected (30 mg/kg), showed no toxicity when the animals were kept in the dark. But, after photoactivation with a 660 nm laser (fluence of 193 J/cm(2)), both photosensitizers, in particular mPEG-Pba, showed a strong efficacy to cure the tumor, both in terms of tumor growth delay and increase of Kaplan-Meier median survival time. Together, our in vivo data demonstrate that mPEG-conjugated Pba is a promising photosensitizer for the photodynamic therapy of cancer.
引用
收藏
页码:192 / 199
页数:8
相关论文
共 53 条
[1]   Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells [J].
Abu-Yousif, Adnan O. ;
Moor, Anne C. E. ;
Zheng, Xiang ;
Savellano, Mark D. ;
Yu, Weiping ;
Selbo, Pal K. ;
Hasan, Tayyaba .
CANCER LETTERS, 2012, 321 (02) :120-127
[2]   Photodynamic Therapy of Cancer: An Update [J].
Agostinis, Patrizia ;
Berg, Kristian ;
Cengel, Keith A. ;
Foster, Thomas H. ;
Girotti, Albert W. ;
Gollnick, Sandra O. ;
Hahn, Stephen M. ;
Hamblin, Michael R. ;
Juzeniene, Asta ;
Kessel, David ;
Korbelik, Mladen ;
Moan, Johan ;
Mroz, Pawel ;
Nowis, Dominika ;
Piette, Jacques ;
Wilson, Brian C. ;
Golab, Jakub .
CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (04) :250-281
[3]   Protein oxidation in aging, disease, and oxidative stress [J].
Berlett, BS ;
Stadtman, ER .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (33) :20313-20316
[4]   Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments [J].
Bhatti, Manpreet ;
Yahioglu, Gokhan ;
Milgrom, Lionel R. ;
Garcia-Maya, Mitla ;
Chester, Kerry A. ;
Deonarain, Mahendra P. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (05) :1155-1163
[5]   The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma [J].
Camerin, Monica ;
Magaraggia, Michela ;
Soncin, Marina ;
Jori, Giulio ;
Moreno, Miguel ;
Chambrier, Isabelle ;
Cook, Michael J. ;
Russell, David A. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (10) :1910-1918
[6]  
Campaner P., 2006, LETT ORG CHEM, V10, P773
[7]   Photodynamic Treatment Induces an Apoptotic Pathway Involving Calcium, Nitric Oxide, p53, p21-Activated Kinase 2, and c-Jun N-Terminal Kinase and Inactivates Survival Signal in Human Umbilical Vein Endothelial Cells [J].
Chan, Wen-Hsiung .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (02) :1041-1059
[8]   Non Polymeric Nanoparticles for Photodynamic Therapy Applications: Recent Developments [J].
Chouikrat, R. ;
Seve, A. ;
Vanderesse, R. ;
Benachour, H. ;
Barberi-Heyob, M. ;
Richeter, S. ;
Raehm, L. ;
Durand, J. -O. ;
Verelst, M. ;
Frochot, C. .
CURRENT MEDICINAL CHEMISTRY, 2012, 19 (06) :781-792
[9]   Silica-based nanoparticles for photodynamic therapy applications [J].
Couleaud, Pierre ;
Morosini, Vincent ;
Frochot, Celine ;
Richeter, Sebastien ;
Raehm, Laurence ;
Durand, Jean-Olivier .
NANOSCALE, 2010, 2 (07) :1083-1095
[10]   Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells [J].
Derycke, ASL ;
Kamuhabwa, A ;
Gijsens, A ;
Roskams, T ;
De Vos, D ;
Kasran, A ;
Huwyler, J ;
Missiaen, L ;
de Witte, PAM .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (21) :1620-1630